Evidence map›Paper›PMID 41325375›Full record

ArticlePLOS global public health2025

Human cysticercosis in Southeastern Côte d'Ivoire: Seroprevalence and risk factors in two rural departments.

Man-Koumba Soumahoro, Kouadio Thierry-Borel N'Dri, Kouassi Eugène Koffi, Mariame Sarranh Fanny, Gildas Boris Tazemda-Kuitsouc, Yves Landry Kangah, Kouadio Narcisse Tano, Kouamé Mathias N'Dri, Cataud Marius Guédé, Offianan André Touré and 4 more

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Man-Koumba SoumahoroDepartment of Epidemiology and Populations' Health, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.ORCID https://orcid.org/0000-0002-6482-3917
Kouadio Thierry-Borel N'DriDepartment of Parasitology Mycology, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Kouassi Eugène KoffiDepartment of Environment and Health, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Mariame Sarranh FannyDepartment of Epidemiology and Populations' Health, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Gildas Boris Tazemda-KuitsoucDepartment of Epidemiology and Populations' Health, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Yves Landry KangahDepartment of Epidemiology and Populations' Health, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Kouadio Narcisse TanoDepartment of Epidemiology and Populations' Health, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Kouamé Mathias N'DriDepartment of Epidemiology and Populations' Health, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.ORCID https://orcid.org/0000-0001-8620-0457
Cataud Marius GuédéDepartment of Epidemiology and Populations' Health, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Offianan André TouréDepartment of Parasitology Mycology, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.
Stéphane PetresRecombinant Protein Platform, Institut Pasteur, Paris, France.
Allico Joseph DjamanUnité de Formation et de Recherche des Biosciences, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.
Mireille NowakowskiRecombinant Protein Platform, Institut Pasteur, Paris, France.
Ronan JambouDepartment of Parasitology Mycology, Institut Pasteur de Côte d'Ivoire, Abidjan, Côte d'Ivoire.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cysticercosis is a parasitic disease caused by Taenia solium, primarily transmitted via fecal-oral route. It is a public health concern because it contributes to increasing morbidity of epilepsy. Its true prevalence remains largely unknown in Côte d'Ivoire. This study aimed to estimate the seroprevalence of cysticercosis in rural southeastern Côte d'Ivoire and identify risk factors. Two cross-sectional cluster sample surveys were conducted in villages in the departments of Dabou and Agboville. Data on socio-demographic, neurological history, knowledge about taeniasis/cysticercosis complex and hygiene behaviors' were collected. A blood sample was collected for serological analysis to detect anti-cysticercosis immunoglobulin G antibodies by ELISA and EITB. The Stata survey command was used for statistical analysis. Qualitative variables were compared using the Chi2 test. A multivariate logistic regression was used to model cysticercosis seropositivity. Cysticercosis seroprevalence was estimated at 9.65% (95%CI: 4.83-18.34%) and 13.11% (95%CI: 9.55-17.74%) in Dabou and Agboville respectively. In Dabou, seropositivity was determined by area of residence and previous knowledge of cysticercosis. The rural population in the Toupah sub-prefecture was more likely to be seropositive (adjusted Odds Ratio [aOR]: 3.53, 95%CI: 1.09-11.44). In Agboville, older adults were 2.74 times more likely to be seropositive than youth at age under 16. Educated individuals (aOR: 0.63, 95%CI: 0.43-0.95), those of muslim faith (aOR: 0.56, 95%CI: 0.34-0.92) and those who reported washing raw vegetables before consumption (aOR: 0.45, 95%CI: 0.22-0.92) had a lower risk. This initial study confirms the circulation of Taenia solium and the endemicity of cysticercosis in these rural regions of south-eastern Côte d'Ivoire, area that supply pigs to markets in Abidjan. Insufficient hygiene practices put communities at high risk of fecal-oral transmission. These findings showed public health issue of cysticercosis in rural areas of Côte d'Ivoire, suggesting that targeted interventions should be considered to reduce transmission and associated neurological problems.

Identifiers

PMID41325375
PMCPMC12668508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.